If using 26-fraction moderate hypofractionation, what dose do you use for the intraprostatic dominant nodule SIB?  

The FLAME trial demonstrated a significant improvement in 5-year DFS, without any significant changes in overall toxicities, when patients being treated to 77 Gy in 35 fractions received a prostate nodule SIB to 95 Gy. 



Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Community Practice